AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
AbbVie (ABBV) shares fell 3.14% on April 10, 2025, with a trading volume of $23.77 billion, ranking 34th in the day's market activity.
Wells Fargo analyst Mohit Bansal maintained a Buy rating on
, setting a price target of $240.00. This rating reflects the firm's confidence in the company's future performance and growth prospects.Morgan Stanley has also raised its price target for AbbVie to $241 from $239, indicating a positive outlook on the company's stock. This adjustment suggests that analysts are optimistic about AbbVie's potential for growth and profitability.
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Dec.19 2025

Dec.19 2025

Dec.19 2025

Dec.18 2025

Dec.18 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet